Revenue: The sum of all revenue fields included for a company's operating activities.
BioMarin Pharmaceutical Inc. (BMRN) had Revenue of $1.02B for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
|
Revenue |
$1.02B |
$-122.83M |
|
$205.42M |
|
$819.23M |
|
$1.11B |
|
$-82.08M |
|
$-49.69M |
|
$-131.77M |
|
$-131.77M |
|
$-122.83M |
|
$-122.83M |
|
$-122.83M |
|
$-122.83M |
|
$-82.08M |
|
$48.38M |
|
193.59M |
|
193.59M |
|
$-0.63 |
|
$-0.63 |
|
| Balance Sheet Financials | |
$3.92B |
|
$980.08M |
|
$7.65B |
|
$11.57B |
|
$1.60B |
|
$3.51B |
|
$3.71B |
|
$5.31B |
|
$6.26B |
|
$812.42M |
|
$6.26B |
|
193.68M |
|
| Cash Flow Statement Financials | |
$576.97M |
|
$-4.68B |
|
$3.53B |
|
$1.31B |
|
$736.01M |
|
$-575.67M |
|
$172.68M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.44 |
|
-- |
|
-- |
|
0.36 |
|
0.67 |
|
79.95% |
|
-8.01% |
|
-8.01% |
|
-- |
|
-12.86% |
|
-11.99% |
|
$498.94M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
0.11 |
|
0.95 |
|
94.54 |
|
-1.96% |
|
-15.12% |
|
-1.06% |
|
-1.26% |
|
$32.30 |
|
$2.58 |
|
$2.98 |
|